CTRA achieved a record-breaking Rp11t in marketing sales for 2024 (+8% yoy), while SMRA underperformed with Rp4.37t (-3.4% yoy), and BSDE is expected to meet its target. In 2025, total marketing sales are forecasted to grow 4.4% yoy. Two main catalysts in 2025 are additional rounds of interest rate cuts and VAT exemptions. The property sector is trading at an undemanding valuation of -1.5SD to the five-year mean discount to RNAV. Maintain OVERWEIGHT. Top picks: BSDE and CTRA.
The JCI delivered a 3.7% decline in 2024, underperforming the MSASJ after two previous years of outperformance. IDXENER was the top performing sector in the JCI with a 31.9% return. IDXFIN dropped 6.2% in 2024 with big banks delivering negative returns. Gains of over 100% have been observed in MLPT, SRAJ, JSPT, PTRO, PANI, CLEO and BRMS. The worst performers are SMGR, UNVR, MDKA, GGRM, TOWR, TLKM and HMSP. For 2025, our top picks are ASII, BMRI, BBNI, BRIS, CMRY, KLBF, SMRA, ACES and GOTO.
Strategy: 2024 JCI Return Analysis: Our top picks are ASII, BMRI, BBNI, BRIS, CMRY, KLBF, SMRA, ACES and GOTO. We have an end-25 target of 8,200 for the JCI. TRADERS’ CORNER Telkom Indonesia (TLKM IJ): Technical BUY Trimegah Bangun Persada (NCKL IJ): Technical BUY
The key takeaways from our regional KL conference are: a) most investors agree that Prabowo’s programmes are positive for Indonesia; b) investors are concerned about the widening budget deficit; c) foreign investors are pleased that local fund managers are buying; d) there is interest in syariah banks, particularly BRIS; and e) investors are inquiring about ACES vs Mr DIY Indonesia. Our top picks are ASII, BMRI, BBNI, BBTN, BRIS, CMRY, KLBF, SMRA, ACES and GOTO.
Strategy: Key Takeaways From Regional Strategy Conference: Our top picks are ASII, BMRI, BBNI, BBTN, BRIS, CMRY, KLBF, SMRA, ACES and GOTO. We have an end-25 target of 8,200 for the JCI. TRADERS’ CORNER PP Persero (PTPP IJ): Technical BUY Bukalapak.com (BUKA IJ): Technical BUY
Trump 2.0 is unlikely to deter Indonesia’s exports to the US as Indonesia should be able to maintain its cost competitiveness. Interest rates are likely to be reduced by 100bp in 2025 and our economist continues to foresee a stronger rupiah. For 2025, investors should focus on the beneficiaries of domestic policies, such as the automobile, banking, consumer, property and technology sectors. Our top picks are BBCA, BBNI, BMRI, BBTN, ASII, SMRA, CTRA, GOTO, CMRY, ACES, SIDO and KLBF.
Strategy: Focus On Beneficiaries Of Domestic Policies: Our top picks are BBCA, BBNI, BMRI, BBTN, ASII, SMRA, CTRA, GOTO, CMRY, ACES, SIDO and KLBF. We have an end-25 target of 8,200 for the JCI. TRADERS’ CORNER Mitra Keluarga Karyasehat (MIKA IJ): Technical BUY Bank Mandiri (BMRI IJ): Technical BUY
Trump 2.0 is unlikely to deter Indonesia’s exports to the US as Indonesia should be able to maintain its cost competitiveness. Interest rates are likely to be reduced by 100bp in 2025 and our economist continues to foresee a stronger rupiah. For 2025, investors should focus on the beneficiaries of domestic policies, such as the automobile, banking, consumer, property and technology sectors. Our top picks are BBCA, BBNI, BMRI, BBTN, ASII, SMRA, CTRA, GOTO, CMRY, ACES, SIDO and KLBF. We have an en...
SMRA posted a strong 2Q24 net profit of Rp312b (+83.4% yoy). Following the sale of Summarecon Mall Kelapa Gading to SMIP, the company is considering an IPO for SMIP. We believe SMIP's valuation has the potential to match or surpass SMRA's current market cap. The newly-launched product in Bogor and new township in Tangerang are expected to boost marketing sales in the following months. We maintain BUY on SMRA with a higher target price of Rp865, driven by the potential IPO, rate cuts and marketin...
GREATER CHINA Sector Hong Kong Developers And Landlords Expect the strong performance of the stock market to have a positive impact on property prices. INDONESIA Update Summarecon Agung (SMRA IJ/BUY/Rp700/Target: Rp865) Potential further re-rating from SMIP IPO and more rate cuts. MALAYSIA Update KPJ Healthcare (KPJ MK/HOLD/RM2.07/Target: RM1.90) KPJ’s transformation programme continues to gathe...
GREATER CHINA Economics Economic Activity 2Q24 growth below expectations. Strategy China And Hong Kong Property Sharper property price decline in 1H24 weighing on margins of Chinese developers; upcoming interest rate cut to support value of Hong Kong retail landlords. Update Kingmed Diagnostics (603882 CH/BUY/Rmb38.10/Target: Rmb35.00) 1H24 and 2024 results under pressu...
SMRA successfully achieved presales of Rp1.7t in 1H24, up 7% yoy and contributing to 34% of its 2024 presales target. However, SMRA is optimistic of achieving its 2024 presales target of Rp5t as it will launch new products and townships in 2H24. We estimate 2024-25 NPAT at Rp906b (+18.3% yoy) and Rp944b (+4.3% yoy) respectively. Maintain BUY with a target price of Rp700 as SMRA’s share price is still attractive and could improve due to rate cut expectations.
We believe marketing sales achievement could improve from 2Q24 onwards as new product launches continue to take place. However, BSDE and SMRA could report softer earnings in 2Q24 after a boost in 1Q24 results, while CTRA could deliver a more consistent revenue growth in 2Q24. We also note that property companies are optimistic in achieving their 2024 presales targets as mortgage rates remain attractive despite the recent interest rate hike. Maintain OVERWEIGHT with CTRA as our top pick.
GREATER CHINA Strategy China And Hong Kong Property: Channel checks and observations of Shanghai/Hong Kong primary markets. Results AAC Technologies (2018 HK/BUY/ HK$22.70/ Target: HK$27.20): 2H23: Slight beat in results; outlook in 2024 seems promising. Sunny Optical (2382 HK/BUY/HK$46.85/Target: HK$63.00): 2023: Results in line but forward shipment guidance weaker than expected. Small/Mid Cap Highlights Crystal International (2232 HK/NOT RATED/HK$3.30): 2023: Results in line with guidance, bul...
SMRA reported 4Q23 net profit of Rp113b, falling 48.5% qoq and 64.2% yoy on declining property deliveries and higher contract liabilities interest expenses. On the other hand, 2023 net profit hiked 22.5% yoy to Rp766t, below our and market estimates. Going forward, with 2024 marketing sales target remaining at Rp5.0t and recurring income growth of 10.6% yoy in 2024-25, we expect NPAT of Rp887b (+15.7% yoy) and Rp944b (+6.5% yoy) respectively. Maintain BUY with a lower target price of Rp700.
GoTo GoJek Tokopedia (GOTO IJ/HOLD/Rp67/Target: Rp69): 4Q23: Rp78.8t impairment – investing in scalable business. Summarecon Agung (SMRA IJ/BUY/Rp525/Target: Rp700): 4Q23: Weakness in NPAT as property deliveries fall; results below expectations. TRADERS’ CORNER Merdeka Copper Gold (MDKA IJ): Technical BUY Summarecon Agung (SMRA IJ): Technical BUY
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.